Nitazoxanide for mild COVID-19 or flu
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether the medicine nitazoxanide, taken as a pill, can help people with mild COVID-19 or flu feel better faster and prevent complications. It is designed for people who are generally healthy and can be treated at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a positive rapid test for COVID-19 or flu and your symptoms started within the last 48 hours.
- You are not pregnant or breastfeeding.
- You have not had chemotherapy, radiation, or a transplant, and you do not have serious liver, kidney, or heart disease.
- You have not taken part in another clinical trial in the last 12 months.
- You do not have a neurological condition (like a stroke or dementia), a developmental disorder, or significant hearing or vision problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well an antiviral works in the body when started early in people with COVID-19 symptoms. You may be able to join if you’re an otherwise healthy adult with confirmed infection and symptoms for less than 4 days.
This trial studies whether PF-07321332 (with ritonavir) helps children under 18 who have COVID-19 at home but are at high risk of severe illness. It looks at whether starting treatment early can reduce progression to worse disease.
This trial tests an oral tablet (SYH2085) to see if it can help adults with the flu feel better faster. If you join, you'll either get the study drug or a placebo (a pill with no medicine).
This trial tests a new drug, ratutrelvir, for people with mild to moderate COVID-19. It aims to find a safe and effective dose to help you feel better faster.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
This study tests a new type of flu prevention medicine (called a monoclonal antibody) given as an injection. It is for people at higher risk of getting the flu, including those with certain health conditions or weakened immune systems.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.